Ontology highlight
ABSTRACT: Objective
The main goal of this work was to identify, describe, characterize, and classify the scientific evidence regarding the use of pharmacogenomic biomarkers in antidepressant treatment.Methods
The work was developed in two phases: i) a search for pharmacogenomic biomarkers in summaries of antidepressant drugs with marketing authorization in Portugal; and ii) a systematic literature review based on the data obtained in the first phase, with the main objective of finding international literature that could describe and characterize previously reported biomarkers and identify other relevant biomarkers. Finally, the levels of evidence and recommendation grades were classified.Results
Among the 26 drugs with marketing authorization in Portugal, only 16 had pharmaco
SUBMITTER: Correia C
PROVIDER: S-EPMC9425945 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature